Last week, Xeltis CEO Eliane Schutte, and CMO Paulo Neves attended the 'Vascular Access Society of the Americas' 2024 Vascular Access for Hemodialysis Symposium in Atlanta, Georgia. Reflecting on this fantastic event that united experts in vascular access, we wanted to highlight our key presentations. CMO Paulo Neves delivered an outstanding presentation on the challenges and complexities of vascular access trials in Europe. His insights on regulatory and cost hurdles, multi-stakeholder involvement, imaging techniques, selecting the right CRO, and identifying ideal trial sites were very well received by all attendees. They were joined by leading KOL Matteo Tozzi, who delivered an insightful presentation on Xeltis' data. His presentation was also well received by the audience, and we were grateful to have him representing Xeltis. See both in action below! #VASA24 #aXess #vascularaccess
Xeltis’ Post
More Relevant Posts
-
AORTO ILIAC CTO - 2 days of loco-regional fibrinolysis (urokinase) from brachial access - recanalization and aorto iliac IVL bilaterally with Shockwave Medical 8/60 - kissing stent (self-expanding) Epic Boston Scientific 9/60 to save all collaterals (hypogastric, lumbar, IMA) with Cecilia Fenelli, Alessio Beconi
-
-
🌟 Sysnav Healthcare is grateful to see Roche presenting a poster on our Syde-derived SV95C at the 21st International Conference on Duchenne and Becker Muscular Dystrophy, hosted by Parent Project aps. Title of the Poster: The Importance and use of Syde® wearable Technology and the Stride Velocity 95th Centile (SV95C) Endpoint in Duchenne muscular dystrophy SV95C is the first digital endpoint to be qualified as a primary endpoint in clinical trials for Duchenne Muscular Dystrophy by a regulatory body (European Medicines Agency). The poster highlights the importance of digital outcome measures and how clinicians and investigators can use them to precisely measure the response of patients to a treatment. This aligns with Sysnav Healthcare's mission to use meaningful real-world data to accelerate medical progress. If you want to learn more about SV95C, you can find the link to the poster in the comments below! #DMD #SV95C #clinicaltrials
-
We are delighted to share an innovative advancement from Biosense Webster, Inc., a valued sponsor of our annual Cardiovascular Tech Forum. As part of Johnson & Johnson MedTech, Biosense Webster has introduced the CARTO™ 3 System Version 8. This latest version employs machine learning to enhance electro-anatomical maps for catheter ablation procedures, notably improving the efficiency and accuracy in treating conditions such as atrial fibrillation (AFib). The new system features sophisticated modules like CARTO ELEVATE™ and CARTOSOUND™ FAM, which integrate artificial intelligence to revolutionize mapping and ablation processes. This significant advancement in cardiac arrhythmia treatment underscores a commitment to precision and patient outcomes. Read more about how Biosense Webster is setting new standards in cardiac care: https://bit.ly/3wA2oH6 #CardiovascularTechForum #CTF2024 #HealthcareInnovation #MedicalTechnology #BiosenseWebster #JohnsonAndJohnson
-
-
Join the webinar to explore real-world applications of the next generation ClosureFastᵀᴹ in clinical settings through case studies and scenarios. Seize the opportunity to participate in a live Q&A session with the experts. 🔗 https://ow.ly/SFf850QjQ85
Join us on 29 January at 16:00 CET, for a patient-outcome-focused broadcast showcasing the Next Gen Closurefast™️ application for varicose vein treatment. 🔗 https://ow.ly/SFf850QjQ85 This broadcast aims to: - Provide insight into Next Gen Closurefast’s key features - Explore its real-world applications - Provide a Q&A with the engineers responsible for its creation and implementation Supported by Medtronic Cardiac and Vascular Vanessa L., Domenico Baccellieri, Juan Manuel Fontcuberta García., Chuanjing Xu, John Elhard, Sarah Thole
-
-
Make sure not to miss out on this excellent webinar!
Join us on 29 January at 16:00 CET, for a patient-outcome-focused broadcast showcasing the Next Gen Closurefast™️ application for varicose vein treatment. 🔗 https://ow.ly/SFf850QjQ85 This broadcast aims to: - Provide insight into Next Gen Closurefast’s key features - Explore its real-world applications - Provide a Q&A with the engineers responsible for its creation and implementation Supported by Medtronic Cardiac and Vascular Vanessa L., Domenico Baccellieri, Juan Manuel Fontcuberta García., Chuanjing Xu, John Elhard, Sarah Thole
-
-
Review the clinical data and real-world experiences presented at the 41st Congress of the ESCRS on Vivinex Gemetric and Vivinex Gemetric Plus IOLs (HOYA Surgical Optics). Erik L. Mertens, MD, FEBO, PCEO, FWCRS, moderated a panel consisting of: Bob Anello; Hakan Kaymak, MD; Ramón Ruiz Mesa, MD, FWCRS; and Dylan A. Joseph, MBChB, Dip(Ophth), FC Ophth, MMed, FWCRS. Read their thoughts on the impressive results in both clinical trials and the real world. #sponsored https://bit.ly/3QGcInD
-
-
It is coming… #ecmo #ecls #mcs #ecpella #ecmella #upperbodyhypoxemia #differentialhypoxemia #harlequinsyndrome #dgfk #vad #mechanicalcirculatorysupport #shock #pci #cardiology #transplantation #interventionalcardiology #covid19 #respiratorydistress #perfusion #cardiopulmonarybypass #aorticvalve #mitralvalve #cardiacsurgery #minimallyinvasive #roboticsurgery #innovation #lifesciences #surgery #medicaldevices #cannula#Kardiotechniker #herzchirurgie #kardiologie
#euroelso2024 - Deadline regular registration fee is approaching fast. Make sure to sign up and be part of our meeting in four weeks time at https://lnkd.in/dY_dpzp5 Beside the outstanding scientific programme we also want to focus you on the Industry sponsored sessions with latest updates and releases presented by experts in our field. Thursday, 25 April 11:45 CARL. – ECPR in the fastlane? and Medtronic - Optimizing ECLS – dual lumen cannulation and oxygenator longevity 18:30 Getinge afternoon symposium Friday, 26 April 07:30 Getinge breakfast symposium & Fresenius Medical Care - Optimizing VA-ECMO care 12:45 Getinge lunch symposium & Eurosets - New born, L-VAS and ECPR outcomes with ECMOLIFE and COLIBRI Saturday, 27 April 07:30 CBM Lifemotion - The future of ECLS technology and The Simulator Company – think simulation
-
-
September is Pulmonary Fibrosis (PF) Awareness Month. #PF is a condition in which scar tissue begins to build up in the lungs, limiting a person’s ability to perform daily activities and, in some cases, even becoming life-threatening. At Brainomix we are focused on developing novel, AI-enabled solutions for PF and other #ILDs, collaborating with world-leading experts to achieve groundbreaking advancements for patients. Open Source Imaging Consortium (OSIC) #CurePF! #PFMonth #BreathingLife
-
-
Book your time slot during #FRPT2023 to talk with THERYQ team about #FlashRT #Flashradiotherapy #cancerresearch #innovation. Happy to get your insights!
Next month THERYQ will be attending #FRPT2023 in Toronto, where we will join leading experts in harnessing the potential of #FLASHRT at this successful multidisciplinary forum. We'll be at booth n°05, showcasing FLASHKNiFE and #FLASHDEEP - our cutting-edge FLASH radiotherapy devices - and discussing our goals to significantly expand the range of treatable #cancers and increase the number of patients living longer, #cancer-free lives. If you are attending the FLASH Radiotherapy & Particle Therapy - FRPT conference, please stop by to chat to us about FLASH #radiationtherapy and share your insights on FLASH, future clinical indications and other trends. We will be holding 1:1 meetings in #Toronto to share our developments with you, learn more about your own projects, and get your guidance on how we can build the future of #FLASH radiotherapy together. To schedule your 1:1 with us, please follow this link to select your time slot. https://lnkd.in/eaTrsZ7K We look forward to seeing you there!
-
-
As we hit the #RoadToEurope we’re showcasing the innovators from around the globe who are selected to present at #LSIEurope24. Today we’re showcasing 3 innovators in Israel selected to present at LSI Europe ‘24 in Portugal: 1. Jordan Pollack — VeinWay Ltd. → Its Traversa catheter has been designed to penetrate blockages with its unique features, including: a steerable needle to maintain navigational control, a 6mm balloon that anchors the device to enhance needle penetration, and a braided catheter that balances catheter strength and flexibility. 2. Dr. Ofir Aharon — PATTERNOX → Developed a handheld scanner that can detect lesion distortions, a warning sign of cancer and cosmetic abnormalities. The device does not rely on ubiquitous color change, but on distortions beneath the skin to detect potentially harmful lesions. 3. Ilan Uchitel — CAPS Medical → Developed a proprietary Non-Thermal Plasma technology (NTAPTM) platform that selectively targets a diverse range of tumors, through minimally invasive procedures, while preserving healthy tissue. We look forward to seeing these innovators take the stage this September 16th - 20th in Portugal. Want to see what other innovators are presenting at LSI Europe ‘24? Head over to our website to see the first 100+ innovators selected to present.
-
